Prosight Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Sell
683,856
-60,086
-8% -$239K 0.4% 30
2025
Q4
$2.61M Sell
743,942
-524,023
-41% -$1.79M 0.54% 29
2025
Q3
$4.13M Sell
1,267,965
-312,623
-20% -$985K 0.99% 28
2025
Q2
$3.87M Buy
1,580,588
+100,588
+7% +$510K 0.94% 28
2025
Q1
$9.87M Buy
1,480,000
+391,294
+36% +$3.87M 3.24% 12
2024
Q4
$13.7M Buy
1,088,706
+929,337
+583% +$14M 3.83% 12
2024
Q3
$2.94M Buy
+159,369
New +$3.26M 0.75% 33
2023
Q1
Sell
-32,193
Closed -$630K 48
2022
Q4
$630K Sell
32,193
-167,807
-84% -$3.09M 0.35% 35
2022
Q3
$3.19M Sell
200,000
-76,802
-28% -$1.2M 1.75% 18
2022
Q2
$3.81M Buy
276,802
+73,534
+36% +$877K 3.09% 13
2022
Q1
$3.22M Buy
203,268
+74,563
+58% +$1.29M 2.27% 15
2021
Q4
$2.81M Buy
+128,705
New +$3.51M 1.87% 19

Other funds holding RCKT